Overview

International Biotechnology Trust tries to achieve long-term capital growth by investing primarily in biotechnology and other life sciences companies that are either quoted or unquoted and possess the potential for high growth. International Biotechnology Trust invests in companies whose shares are considered to have good prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

You can access the manager’s website here

Fundamentals

Ticker
IBT
Exchange
XLON
Domicile
GBR
Sector
Healthcare
Market Capitalisation (M)
235
Share Price (GBP)
7.02
12 Month Trailing Dividend Yield
3.63%

Price

Research History

News

In The Press

Data